The chemerin production changes in obese patients with different carbohydrate metabolism state
- 1 November 2017
- journal article
- Published by Institute of Biochemistry in Biomeditsinskaya Khimiya
- Vol. 63 (6) , 582-590
Abstract
Chemerin is a mediator of adipose tissue involved in the regulation of many processes, including lipogenesis, and inflammatory response. The role of chemerin in the development of insulin resistance has been insufficiently studied and needs detailed understanding. The aim of the study was to investigate chemerin production in obese patients with different states of carbohydrate metabolism. The study included 155 patients with a diagnosis of obesity; 34 patients with overweight. The control group 1 consisted of 43 conditionally healthy donors who did not have obesity. For comparison of the results of a study to determine the levels of tissue-specific mRNA expression of the genes IL-6, TNF-a, RARRES2, (encoding IL-6, TNF-a and chemerin) in adipose tissue introduced a control group 2 – 30 patients without obesity. Study on the relative level of mRNA expression of the genes IL-6, TNF-a and RARRES2 (encoding IL-6, TNF-a and chemerin) was carried out using real time PCR. Concentrations of IL-6, TNF-a, and chemerin were measured in serum/plasma using an enzyme-linked immunosorbent assay (ELISA). We found significant differences in the plasma level of chemerin and tissue-specific features of RARRES2 gene expression in obese patients, depending on the degree of obesity and the state of carbohydrate metabolism. Multidirectional associations of RARRES2 gene expression with TNF-a and IL-6 genes in adipose tissues of different localization are shown: in obese patients (BMI £40 kg/m2) without type 2 diabetes – negative, and type 2 diabetes – positive. Identified relationship chemerin plasma content and the expression level of its gene in biopsies with various parameters of carbohydrate and lipid metabolism, proinflammatory molecules indicate chemerin involved in metabolic and immune processes in obesity.Keywords
This publication has 22 references indexed in Scilit:
- Serum chemerin is associated with inflammatory and metabolic parameters—results of a population‐based studyObesity, 2017
- Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?Clinical Science, 2016
- Chemerin as an independent predictor of cardiovascular event riskTherapeutic Advances in Endocrinology and Metabolism, 2016
- Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences, 2014
- Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patientsClinical and Experimental Hypertension, 2013
- Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphismEndocrine Journal, 2013
- Chemerin levels are positively correlated with abdominal visceral fat accumulationClinical Endocrinology, 2012
- Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesityMetabolism, 2012
- Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cellsJournal of Bone and Mineral Research, 2010
- Proteolytic regulatory mechanism of chemerin bioactivityActa Biochimica et Biophysica Sinica, 2009